Previous Close | 11.24 |
Open | 10.98 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 10.60 - 11.20 |
52 Week Range | 10.60 - 80.80 |
Volume | |
Avg. Volume | 13,903 |
Market Cap | 13.703M |
Beta (5Y Monthly) | 0.50 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -21.60 |
Earnings Date | May 08, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BOSTON, MA / ACCESSWIRE / April 19, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective ...
BOSTON, MA / ACCESSWIRE / March 27, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) provided a corporate update today announcing a strategy to maximize its ability to capture the potential milestones from its 4-1BB bispecific Mabcalin® (antibody-Anticalin ...
To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. ( NASDAQ:PIRS ) shares are down a considerable 27...